Sorry, you need to enable JavaScript to visit this website.

TRUMENBA® (Meningococcal Group B Vaccine) Indications and Usage

1 INDICATIONS AND USAGE

Trumenba is indicated for active immunization to prevent invasive disease caused by Neisseria meningitidis serogroup B. Trumenba is approved for use in individuals 10 through 25 years of age.

The effectiveness of the two-dose schedule of Trumenba against diverse N. meningitidis serogroup B strains has not been confirmed.

Did you find an answer to your question? Yes No
Did you find an answer to your question? Yes No